|
|
|
Volumn 66, Issue 6 Suppl, 2000, Pages 19-24
|
|
Evaluating the potential clinical benefits of switching patients with plaque psoriasis from calcipotriene to tazarotene treatment.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CALCIPOTRIOL;
CALCITRIOL;
DERMATOLOGICAL AGENT;
DRUG DERIVATIVE;
GLUCOCORTICOID;
NICOTINIC ACID DERIVATIVE;
TAZAROTENE;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG COMBINATION;
EVALUATION;
FEMALE;
HOSPITALIZATION;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PATIENT SATISFACTION;
PSORIASIS;
TOPICAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ADMINISTRATION, TOPICAL;
ANTI-INFLAMMATORY AGENTS;
CALCITRIOL;
DERMATOLOGIC AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
MALE;
MIDDLE AGED;
NICOTINIC ACIDS;
PATIENT SATISFACTION;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 0034566682
PISSN: 00114162
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
